RICHARD WAHL was named the Elizabeth E. Mallinckrodt Professor and head of radiology at Washington University School of Medicine in St. Louis. He also will serve as director of the Mallinckrodt Institute of Radiology. He will begin in October.
A group of melanoma experts, joined by three advocacy groups focused on melanoma, has engaged FDA in a public discussion of the challenges of developing new drugs in the refractory setting and the role crossover can play in such trials.
